TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/20/21 17:00 | 9/16/21 | MGTA | Magenta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Beetham Thomas W. | MA | O | See Rema | S | -41 | 6.73 | 0 | -6 | -31 | 14 | D | ||||||||||||||
2/5/21 18:55 | 2/3/21 | KNSA | Kiniksa Pharmaceuticals, Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Beetham Thomas W. | D0 | O | EVP,GC | S.d | -55 | 22.09 | 0 | -2 | -1 | 298 | D | ||||||||||||||
7/2/20 16:13 | 7/1/20 | KNSA | Kiniksa Pharmaceuticals, Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Beetham Thomas W. | D0 | O | EVP,GC | S | -751 | 25.37 | 0 | -30 | -100 | 0 | D | ||||||||||||||
6/12/20 17:50 | 6/10/20 | KNSA | Kiniksa Pharmaceuticals, Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Beetham Thomas W. | D0 | O | EVP,GC | S.d | -345 | 25.07 | 0 | -14 | -32 | 30 | D | ||||||||||||||
4/22/20 17:39 | 4/20/20 | KNSA | Kiniksa Pharmaceuticals, Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Beetham Thomas W. | D0 | O | EVP,GC | S.m | -954 | 19.10 | 0 | -50 | -63 | 30 | D | ||||||||||||||
2/19/20 17:24 | 2/14/20 | KNSA | Kiniksa Pharmaceuticals, Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Beetham Thomas W. | D0 | O | EVP,GC | S | -1 | 18.58 | 0 | 0 | 0 | 80 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |